PerkinElmer, Inc.
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutio…
Insiders
Transactions
Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
---|---|---|---|---|---|---|---|
$19,852
d
cs
10% Holder
|
01/07/25 |
S
|
474 x $117.79 = $55,832.46 |
Footnotes
#1 The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error.
#2 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
#3 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $115.62 to $116.58. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
#4 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $116.69 to $117.60. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
#5 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $117.71 to $117.88. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
|
|||
$19,652
d
cs
10% Holder
|
01/07/25 |
S
|
200 x $118.92 = $23,784.00 |
Footnotes
#1 The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error.
#2 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
#3 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $115.62 to $116.58. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
#4 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $116.69 to $117.60. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
#5 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $117.71 to $117.88. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
|
|||
$25,144
d
cs
10% Holder
|
01/07/25 |
M
|
5,492 x $81.29 = $446,444.68 |
Footnotes
#1 The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error.
#2 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
#3 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $115.62 to $116.58. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
#4 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $116.69 to $117.60. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
#5 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $117.71 to $117.88. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
|
|||
$22,714
d
cs
10% Holder
|
01/07/25 |
S
|
2,430 x $116.13 = $282,195.90 |
Footnotes
#1 The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error.
#2 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
#3 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $115.62 to $116.58. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
#4 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $116.69 to $117.60. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
#5 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $117.71 to $117.88. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
|
|||
$20,326
d
cs
10% Holder
|
01/07/25 |
S
|
2,388 x $117.14 = $279,730.32 |
Footnotes
#1 The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error.
#2 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
#3 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $115.62 to $116.58. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
#4 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $116.69 to $117.60. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
#5 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $117.71 to $117.88. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
|
Get PRO Today
With PRO you will unlock 94 more insider transactions for PerkinElmer, Inc.
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Barrett Peter Director
- Chapin Samuel R. Director
- Goldberg Joel S Please See Remarks
- Gonzales Anita Please See Remarks
- Gregoire Sylvie Director
- Klobuchar Michael A Director
- Krakowiak Maxwell Please See Remarks
- Mcmurry-Heath Michelle Director
- Michas Alexis P Director
- Singh Prahlad R. Please See Remarks
- Tereau Daniel R Please See Remarks
- Vandebroek Sophie V. Director
- Victor Miriame Please See Remarks
- Vohra Tajinder S Please See Remarks
- Vounatsos Michel Director
- Witney Frank Director
- Witz Pascale Director
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Barrett Peter Director
- Chapin Samuel R. Director
- Goldberg Joel S Please See Remarks
- Gonzales Anita Please See Remarks
- Gregoire Sylvie Director
- Klobuchar Michael A Director
- Krakowiak Maxwell Please See Remarks
- Mcmurry-Heath Michelle Director
- Michas Alexis P Director
- Singh Prahlad R. Please See Remarks
- Tereau Daniel R Please See Remarks
- Vandebroek Sophie V. Director
- Victor Miriame Please See Remarks
- Vohra Tajinder S Please See Remarks
- Vounatsos Michel Director
- Witney Frank Director
- Witz Pascale Director